Stay updated on ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Sign up to get notified when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a website/system update rather than a change to the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T05:53:13.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The study status is updated to Completed with new dates (2026-04-15; 2026-03-05; 2026-04-07; 2026-04) and revision v3.5.2, and the previous Active, not recruiting status along with its earlier dates and revision v3.5.0 were removed.
    Difference
    0.4%
    Check dated 2026-04-17T02:36:36.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Site revision tag updated to Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T05:11:57.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T02:49:30.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Updated study details add a core biopsy requirement for ER IHC and PD testing, and introduce dose escalation with an RP2D plus a palbociclib combination cohort. ARV-471 dosing for Parts A and B is now specified as QD or BID for 28-day cycles, with pharmacokinetic endpoints (AUC) included.
    Difference
    0.8%
    Check dated 2026-02-11T14:15:53.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a government funding lapse notice indicating NIH Clinical Center status and updated the system revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:25:06.000Z thumbnail image

Stay in the know with updates to ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.